|By Marketwired .||
|March 28, 2014 02:30 PM EDT||
TORONTO, ONTARIO -- (Marketwired) -- 03/28/14 -- PharmaCan Capital is pleased to announce that it has lent money to certain Licensed Producers under the MMPR, including a loan to Whistler Medical Marijuana Corp. ("WMMC"), a company that PharmaCan has previously invested in. "All of the loans were negotiated quickly and we are pleased that we could deploy capital to support and accelerate our partner's growth in a timely fashion," said PharmaCan Capital CEO Paul Rosen.
"With the completion of our recent $9,000,000 financing we are uniquely positioned to fund the growth and development of Licensed Producers and applicants under MMPR," Mr. Rosen explained. "PharmaCan Capital is and will always be an equity investor and we have now demonstrated our ability to lend capital to LPs where the use of proceeds is clearly opportunistic. We continue to look for investment opportunities and are pleased to support Health Canada's MMPR by being an early stage provider of capital to the industry."
Chris Pelz, the founder and majority shareholder of Whistler Medical Marijuana Corp. commented that, "PharmaCan has been a sensational partner to WMMC from day one of their involvement pre-licensing." Mr. Pelz continued, "Last week we were presented a unique opportunity available only to LP's that required immediate access to capital and PharmaCan had the money in our account less than 48 hours after we approached them. PharmaCan is a true partner and cares as much as I do about building Whistler into a world-class company. Their value to the Whistler Medical Marijuana Corp. goes a lot deeper than just writing cheques but last week that ability was singularly helpful."
About PharmaCan Capital
PharmaCan Capital is a Canadian company actively pursuing investment opportunities in the medical and legal cannabis industries. PharmaCan has made three investments in Canadian commercial growers, and to date, two have obtained a license to distribute medical marihuana from Health Canada.
Jul. 6, 2015 11:35 AM EDT
Jul. 6, 2015 11:30 AM EDT Reads: 1,613
Jul. 6, 2015 11:30 AM EDT Reads: 2,264
Jul. 6, 2015 11:15 AM EDT Reads: 1,648
Jul. 6, 2015 11:15 AM EDT Reads: 1,391
Jul. 6, 2015 11:15 AM EDT Reads: 1,597
Jul. 6, 2015 11:15 AM EDT Reads: 2,115
Jul. 6, 2015 11:00 AM EDT Reads: 2,506
Jul. 6, 2015 11:00 AM EDT Reads: 563
Jul. 6, 2015 11:00 AM EDT Reads: 2,041
Jul. 6, 2015 10:45 AM EDT Reads: 1,695
Jul. 6, 2015 10:30 AM EDT Reads: 1,380
The enterprise market will drive IoT device adoption over the next five years. In his session at @ThingsExpo, John Greenough, an analyst at BI Intelligence, division of Business Insider, analyzed how companies will adopt IoT products and the associated cost of adopting those products. John Greenough is the lead analyst covering the Internet of Things for BI Intelligence- Business Insider’s paid research service. Numerous IoT companies have cited his analysis of the IoT. Prior to joining BI In...
Jul. 6, 2015 10:15 AM EDT Reads: 431
Containers are changing the security landscape for software development and deployment. As with any security solutions, security approaches that work for developers, operations personnel and security professionals is a requirement. In his session at DevOps Summit, Kevin Gilpin, CTO and Co-Founder of Conjur, will discuss various security considerations for container-based infrastructure and related DevOps workflows.
Jul. 6, 2015 10:15 AM EDT Reads: 1,642
In his session at 16th Cloud Expo, Simone Brunozzi, VP and Chief Technologist of Cloud Services at VMware, reviewed the changes that the cloud computing industry has gone through over the last five years and shared insights into what the next five will bring. He also chronicled the challenges enterprise companies are facing as they move to the public cloud. He delved into the "Hybrid Cloud" space and explained why every CIO should consider ‘hybrid cloud' as part of their future strategy to achie...
Jul. 6, 2015 10:00 AM EDT Reads: 1,696